Automated washing of human progenitor cells: Evaluation of apoptosis and cell necrosis

M. C. Scerpa, N. Daniele, F. Landi, M. Caniglia, A. M. Cometa, C. Ciammetti, C. Rossi, F. Locatelli, G. Isacchi, F. Zinno

Research output: Contribution to journalArticle

Abstract

Background: High-dose chemotherapy followed by reinfusion of autologous stem cells harvested from peripheral blood has been increasingly applied for a variety of disorders. The critical importance of cell dose in the clinical outcome, after transplant, has motivated the need to develop techniques aimed at reducing cell losses and increasing reproducibility. Objectives: The aim of this study is to evaluate the efficacy of the Sepax S-100 device to process thawed HPC-A products in comparison with manual procedure. Methods/Materials: We have analysed viability, total nucleated cells (TNC), haematopoietic progenitors and CD34+ cells recovery. Results: The TNC and CD34+ cells recovery in the automatic procedure was of 91·9% (73-100; SD ± 12·60) and 86·7% (69-100; SD ± 10·21), respectively. Instead the recovery of TNC and CD34+ cells using the manual method was of 84·7% (47-100; SD ± 22·9) and 80·29% (23-100; SD ± 25·96). The results, obtained from the assessment of viability of CD34+ both 7-AAD)+ and AnnV+ showed a high percentage of necrosis and apoptosis in this cell subset by using the manual procedure in respect to the Sepax automated system. Conclusion: Overall, our data suggest that the automated washing procedure is safe and suitable for processing of thawed HPC-A products and can be daily used in clinical routine.

Original languageEnglish
Pages (from-to)402-407
Number of pages6
JournalTransfusion Medicine
Volume21
Issue number6
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Necrosis
Stem Cells
Apoptosis
Transplants
Drug Therapy
Equipment and Supplies

Keywords

  • 7-AAD
  • AnnexinV
  • CD34+ cells
  • HPC-A thawing

ASJC Scopus subject areas

  • Hematology

Cite this

Scerpa, M. C., Daniele, N., Landi, F., Caniglia, M., Cometa, A. M., Ciammetti, C., ... Zinno, F. (2011). Automated washing of human progenitor cells: Evaluation of apoptosis and cell necrosis. Transfusion Medicine, 21(6), 402-407. https://doi.org/10.1111/j.1365-3148.2011.01103.x

Automated washing of human progenitor cells : Evaluation of apoptosis and cell necrosis. / Scerpa, M. C.; Daniele, N.; Landi, F.; Caniglia, M.; Cometa, A. M.; Ciammetti, C.; Rossi, C.; Locatelli, F.; Isacchi, G.; Zinno, F.

In: Transfusion Medicine, Vol. 21, No. 6, 12.2011, p. 402-407.

Research output: Contribution to journalArticle

Scerpa, MC, Daniele, N, Landi, F, Caniglia, M, Cometa, AM, Ciammetti, C, Rossi, C, Locatelli, F, Isacchi, G & Zinno, F 2011, 'Automated washing of human progenitor cells: Evaluation of apoptosis and cell necrosis', Transfusion Medicine, vol. 21, no. 6, pp. 402-407. https://doi.org/10.1111/j.1365-3148.2011.01103.x
Scerpa, M. C. ; Daniele, N. ; Landi, F. ; Caniglia, M. ; Cometa, A. M. ; Ciammetti, C. ; Rossi, C. ; Locatelli, F. ; Isacchi, G. ; Zinno, F. / Automated washing of human progenitor cells : Evaluation of apoptosis and cell necrosis. In: Transfusion Medicine. 2011 ; Vol. 21, No. 6. pp. 402-407.
@article{11b9b66ad0b64d318cce47932c27c4ad,
title = "Automated washing of human progenitor cells: Evaluation of apoptosis and cell necrosis",
abstract = "Background: High-dose chemotherapy followed by reinfusion of autologous stem cells harvested from peripheral blood has been increasingly applied for a variety of disorders. The critical importance of cell dose in the clinical outcome, after transplant, has motivated the need to develop techniques aimed at reducing cell losses and increasing reproducibility. Objectives: The aim of this study is to evaluate the efficacy of the Sepax S-100 device to process thawed HPC-A products in comparison with manual procedure. Methods/Materials: We have analysed viability, total nucleated cells (TNC), haematopoietic progenitors and CD34+ cells recovery. Results: The TNC and CD34+ cells recovery in the automatic procedure was of 91·9{\%} (73-100; SD ± 12·60) and 86·7{\%} (69-100; SD ± 10·21), respectively. Instead the recovery of TNC and CD34+ cells using the manual method was of 84·7{\%} (47-100; SD ± 22·9) and 80·29{\%} (23-100; SD ± 25·96). The results, obtained from the assessment of viability of CD34+ both 7-AAD)+ and AnnV+ showed a high percentage of necrosis and apoptosis in this cell subset by using the manual procedure in respect to the Sepax automated system. Conclusion: Overall, our data suggest that the automated washing procedure is safe and suitable for processing of thawed HPC-A products and can be daily used in clinical routine.",
keywords = "7-AAD, AnnexinV, CD34+ cells, HPC-A thawing",
author = "Scerpa, {M. C.} and N. Daniele and F. Landi and M. Caniglia and Cometa, {A. M.} and C. Ciammetti and C. Rossi and F. Locatelli and G. Isacchi and F. Zinno",
year = "2011",
month = "12",
doi = "10.1111/j.1365-3148.2011.01103.x",
language = "English",
volume = "21",
pages = "402--407",
journal = "Transfusion Medicine",
issn = "0958-7578",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Automated washing of human progenitor cells

T2 - Evaluation of apoptosis and cell necrosis

AU - Scerpa, M. C.

AU - Daniele, N.

AU - Landi, F.

AU - Caniglia, M.

AU - Cometa, A. M.

AU - Ciammetti, C.

AU - Rossi, C.

AU - Locatelli, F.

AU - Isacchi, G.

AU - Zinno, F.

PY - 2011/12

Y1 - 2011/12

N2 - Background: High-dose chemotherapy followed by reinfusion of autologous stem cells harvested from peripheral blood has been increasingly applied for a variety of disorders. The critical importance of cell dose in the clinical outcome, after transplant, has motivated the need to develop techniques aimed at reducing cell losses and increasing reproducibility. Objectives: The aim of this study is to evaluate the efficacy of the Sepax S-100 device to process thawed HPC-A products in comparison with manual procedure. Methods/Materials: We have analysed viability, total nucleated cells (TNC), haematopoietic progenitors and CD34+ cells recovery. Results: The TNC and CD34+ cells recovery in the automatic procedure was of 91·9% (73-100; SD ± 12·60) and 86·7% (69-100; SD ± 10·21), respectively. Instead the recovery of TNC and CD34+ cells using the manual method was of 84·7% (47-100; SD ± 22·9) and 80·29% (23-100; SD ± 25·96). The results, obtained from the assessment of viability of CD34+ both 7-AAD)+ and AnnV+ showed a high percentage of necrosis and apoptosis in this cell subset by using the manual procedure in respect to the Sepax automated system. Conclusion: Overall, our data suggest that the automated washing procedure is safe and suitable for processing of thawed HPC-A products and can be daily used in clinical routine.

AB - Background: High-dose chemotherapy followed by reinfusion of autologous stem cells harvested from peripheral blood has been increasingly applied for a variety of disorders. The critical importance of cell dose in the clinical outcome, after transplant, has motivated the need to develop techniques aimed at reducing cell losses and increasing reproducibility. Objectives: The aim of this study is to evaluate the efficacy of the Sepax S-100 device to process thawed HPC-A products in comparison with manual procedure. Methods/Materials: We have analysed viability, total nucleated cells (TNC), haematopoietic progenitors and CD34+ cells recovery. Results: The TNC and CD34+ cells recovery in the automatic procedure was of 91·9% (73-100; SD ± 12·60) and 86·7% (69-100; SD ± 10·21), respectively. Instead the recovery of TNC and CD34+ cells using the manual method was of 84·7% (47-100; SD ± 22·9) and 80·29% (23-100; SD ± 25·96). The results, obtained from the assessment of viability of CD34+ both 7-AAD)+ and AnnV+ showed a high percentage of necrosis and apoptosis in this cell subset by using the manual procedure in respect to the Sepax automated system. Conclusion: Overall, our data suggest that the automated washing procedure is safe and suitable for processing of thawed HPC-A products and can be daily used in clinical routine.

KW - 7-AAD

KW - AnnexinV

KW - CD34+ cells

KW - HPC-A thawing

UR - http://www.scopus.com/inward/record.url?scp=81255157436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255157436&partnerID=8YFLogxK

U2 - 10.1111/j.1365-3148.2011.01103.x

DO - 10.1111/j.1365-3148.2011.01103.x

M3 - Article

C2 - 22032614

AN - SCOPUS:81255157436

VL - 21

SP - 402

EP - 407

JO - Transfusion Medicine

JF - Transfusion Medicine

SN - 0958-7578

IS - 6

ER -